Cargando…

IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer

Emerging evidence indicates that IGF2 plays an important role in various human malignancies, including colorectal cancer (CRC). Hsa-miR-483 is located within intron 7 of the IGF2 locus. However, the mechanism by which increased IGF2 induces carcinogenesis remains largely elusive. DLC-1 has been iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Hengmi, Liu, Yuan, Jiang, Jingrui, Liu, Yangyang, Yang, Zhe, Wu, Shaogen, Cao, Wangsen, Cui, Isabelle H., Yu, Chenggong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217031/ https://www.ncbi.nlm.nih.gov/pubmed/27366946 http://dx.doi.org/10.18632/oncotarget.10309

Ejemplares similares

The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis
por: Liu, Mingzhu, et al.
Publicado: (2013)

CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors
por: Zhang, Yiqun, et al.
Publicado: (2016)

MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma
por: Tang, Shaohui, et al.
Publicado: (2017)

MiR-483 induces senescence of human adipose-derived mesenchymal stem cells through IGF1 inhibition
por: Shen, Junyan, et al.
Publicado: (2020)

Loss of Imprinting of IGF2 as an Epigenetic Marker for the Risk of Human Cancer
por: Cui, Hengmi
Publicado: (2007)

IGF2‐derived miR‐483‐3p associated with Hirschsprung's disease by targeting FHL1
por: Zhi, Zhengke, et al.
Publicado: (2018)

ZBED6 regulates Igf2 expression partially through its regulation of miR483 expression
por: Naboulsi, Rakan, et al.
Publicado: (2021)

Obtaining Patient-Reported Outcomes Electronically With “OncoFunction” in Head and Neck Cancer Patients During Aftercare
por: Zebralla, Veit, et al.
Publicado: (2020)

Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban
por: Zhang, Hanxu, et al.
Publicado: (2022)

MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells
por: Gailhouste, Luc, et al.
Publicado: (2019)

Inhibition of the epigenetically activated miR-483-5p/IGF-2 pathway results in rapid loss of meningioma tumor cell viability
por: Uhlmann, Erik J., et al.
Publicado: (2023)

Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers
por: Zheng, Xiao-Hui, et al.
Publicado: (2014)

MiR-143 and MiR-145 Regulate IGF1R to Suppress Cell Proliferation in Colorectal Cancer
por: Su, Jiaojiao, et al.
Publicado: (2014)

MiR-483 Targeted SOX3 to Suppress Glioma Cell Migration, Invasion and Promote Cell Apoptosis
por: Lu, Shujing, et al.
Publicado: (2020)

miR-483-5p Targets MKNK1 to Suppress Wilms’ Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo
por: Liu, Kai, et al.
Publicado: (2019)

Epigenetic alterations of the Igf2 promoter and the effect of miR-483-5p on its target gene expression in esophageal squamous cell carcinoma
por: Zhang, Han, et al.
Publicado: (2018)

Role of miR-483 in digestive tract cancers: from basic research to clinical value
por: Zhou, Wei, et al.
Publicado: (2018)

Circulating miR-19a-3p and miR-483-5p as Novel Diagnostic Biomarkers for the Early Diagnosis of Gastric Cancer
por: Cheng, Jieyao, et al.
Publicado: (2020)

Imprinting Status of IGF2 in Cord Blood Cells of Han Chinese Newborns
por: Dai, Yimin, et al.
Publicado: (2007)

Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
por: ABUE, MAKOTO, et al.
Publicado: (2014)

miR-483 is Down-Regulated in Polycystic Ovarian Syndrome and Inhibits KGN Cell Proliferation via Targeting Insulin-Like Growth Factor 1 (IGF1)
por: Xiang, Yungai, et al.
Publicado: (2016)

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1
por: Liao, Yi-Chun, et al.
Publicado: (2007)

MicroRNA‐483 amelioration of experimental pulmonary hypertension
por: Zhang, Jin, et al.
Publicado: (2020)

MiR‐483‐3p improves learning and memory abilities via XPO1 in Alzheimer's disease
por: Luo, Gang, et al.
Publicado: (2022)

miR-429 promotes the proliferation of non-small cell lung cancer cells via targeting DLC-1
por: Xiao, Peng, et al.
Publicado: (2021)

DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016)

New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
por: Salvianti, Francesca, et al.
Publicado: (2017)

The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer
por: Pepe, Felice, et al.
Publicado: (2018)

Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality()
por: Giuliani, Angelica, et al.
Publicado: (2022)

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
por: Li, Yao, et al.
Publicado: (2023)

Hsa_circ_0123190 acts as a competitive endogenous RNA to regulate APLNR expression by sponging hsa-miR-483-3p in lupus nephritis
por: Zhang, Chunyi, et al.
Publicado: (2021)

Arctigenin inhibits apoptosis, extracellular matrix degradation, and inflammation in human nucleus pulposus cells by up‐regulating miR‐483‐3p
por: Ji, Zhe, et al.
Publicado: (2022)

Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
por: Oreglia, Maurine, et al.
Publicado: (2020)

Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
por: Gallo, Widet, et al.
Publicado: (2021)

Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors
por: Huang, Wen-Kuan, et al.
Publicado: (2021)

Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis
por: Cui, Zhe, et al.
Publicado: (2014)

Downregulation of DLC-1 Gene by Promoter Methylation during Primary Colorectal Cancer Progression
por: Peng, Haixia, et al.
Publicado: (2013)

Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients
por: Elfert, Ashraf Y., et al.
Publicado: (2022)

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma
por: Lupini, Laura, et al.
Publicado: (2016)

THU560 Serum miRNA-483 As A Diagnostic And Therapeutic Marker Of IGF-II-producing Non-islet Cell Tumor Hypoglycemia (NICTH)
por: Okazaki-Hada, Mikiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b7tfei0t52bhafd6r2oias94mf